Researchers in Italy announced on December 30, 2019, that they had discovered two previously unknown cannabinoids, THCP and CBDP.
The first, tetrahydrocannabiphorol (Δ9-THCP), is allegedly 30 times more potent than THC. In mice, it appeared THCP was more active than THC at lower doses.
The scientists also found cannabidiphorol (CBDP), a CBD cousin, and are investigating CBDP’s anti-convulsive and anti-inflammatory properties.
THCP and CBDP may be more abundant in other cannabis strains, but it would take time to conduct more research.
It’s not yet clear how CBDP would work. With that said, CBD has a bad binding affinity to CB1 and CB2 receptors.
Should CBDP has a better binding affinity to people identical receptors, then CBDP could provide comparable positive aspects of CBD but at a much higher potency.
The strain, FM2, a cannabis variety, is obtained from the strain CIN-RO produced by the Council for Agricultural Research and Economics (CREA) in Rovigo (Italy) and provided to the Military Chemical Pharmaceutical Institute (MCPI, Firenze, Italy) for breeding.